2nd Quarter - Report

SOLUGEN INC for SOLUGEN INC

Firm
Client
Income
—
Expenses
$180,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Support the use of bio-based chemicals in the Department of Defense; educate and advocate for secure supply chains in the FY 2025 National Defense Authorization Act.

LobbyistCovered position, as disclosed
HENRY HOLBROOK New —
BRYAN J. SOUKUP —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; Defense, Dept of (DOD)

Environment/Superfund ENV

Educate policymakers about Solugen's technology to produce bio-based chemicals; monitor P.L.117-58, Infrastructure Investment and Jobs Act; monitor P.L. 117-169, Inflation Reduction Act. Monitor implementation of Executive Order on Advancing Biotechnology and Biomanufacturing. Educate policymakers on the Premanufacture Notice decision for glucaric acid under TSCA and on the Environmental Protection Agency's chemical review process.

LobbyistCovered position, as disclosed
HENRY HOLBROOK New —
BRYAN J. SOUKUP —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Environmental Protection Agency (EPA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.